Quarterly report pursuant to Section 13 or 15(d)

Significant Transactions (Narrative) (Details)

v3.22.2.2
Significant Transactions (Narrative) (Details) - USD ($)
 3 Months Ended
Nov. 01, 2021
Aug. 23, 2021
Sep. 30, 2022
Sep. 30, 2021
Amortization of deferred financing costs     $ 40,000 $ 0
Stock purchase agreement, value of shares to be purchased     $ 0 $ 2,500,000
College Station Investors LLC And Bryan Capital [Member]        
Total purchase price $ 28,750,000      
Cash payment 28,000,000      
Fair market value of property $ 151,450      
Percentage of base rent 6.50%      
Cash consideration for equity interest acquired $ 50,000      
Number of warrants issued 51,583      
Warrants, exercise price per share $ 33.25      
Shares issued under the Warrant 11,583      
Fair value of the warrant $ 217,255      
College Station Investors LLC And Bryan Capital [Member] | Secured Term Loan        
Secured term loan $ 22,375,000      
Interest rate (as percent) 3.25%      
Unrestricted cash $ 10,000,000      
Irrevocable letter of credit $ 5,469,000      
College Station Investors LLC And Bryan Capital [Member] | IBio CMO Preferred Tracking Stock        
Warrants issuable 1      
Percentage of equity interest 0.01%      
Collaboration, Option and License Agreement [Member] | Immune-Oncology Antibodies (RTX-003) [Member] | RubrYc Theraputics, Inc. [Member]        
Collaboration and license agreement, agreement term   5 years    
Collaboration, Option and License Agreement [Member] | Immune-Oncology Antibodies (RTX-003) [Member] | No Biosimilar Product has been Approved [Member] | RubrYc Theraputics, Inc. [Member]        
Collaboration and license agreement, royalty payment term   10 years    
Series A-2 Preferred Stock [Member] | Stock Purchase Agreement [Member] | Immune-Oncology Antibodies (RTX-003) [Member] | RubrYc Theraputics, Inc. [Member]        
Stock purchase agreement, number of shares purchased   2,864,345    
Stock purchase agreement, value of shares purchased   $ 7,500,000